Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Comment] An appealing new agent for treating cholestatic pruritus

Management of cholestatic pruritus is challenged by the uncertainty of its pathogenesis, which is related to various components of bile, but could also be mediated by increased opioidergic neurotransmission and other pathways.1 Ursodeoxycholic acid (UDCA) does not ameliorate cholestatic itch except in intrahepatic cholestasis of pregnancy. Resins such as cholestyramine and colestipol are widely used as first-line treatments although the evidence base for these interventions is small.2 Moreover, patients can have poor tolerance because of taste and abdominal disturbances, and might discontinue therapy.